Effects of the cannabinoid CB 1 receptor antagonist, SR141716A, after 9 -tetrahydrocannabinol withdrawal

By Beardsley P.M.   Martin B.R.  

European Journal of Pharmacology, Vol. 387, Iss. 1, 2000-11 ,pp. : 47-53

Elsevier

Access to resources Recommend Favorite

SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice

By Richardson J.D.   Aanonsen L.   Hargreaves K.M.  

European Journal of Pharmacology, Vol. 319, Iss. 2, 1997-01 ,pp. : 3-4

Elsevier

Access to resources Recommend Favorite

The cannabinoid receptor antagonist SR-141716 does not readily antagonize open-field effects induced by the cannabinoid receptor agonist (R)-methanandamide in rats

By Jarbe T.U.C.   DiPatrizio N.V.   Li C.   Makriyannis A.  

Pharmacology Biochemistry and Behavior, Vol. 75, Iss. 4, 2003-07 ,pp. : 809-821

Elsevier

Access to resources Recommend Favorite

The cannabinoid CB 1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2

By Darmani N.A.  

European Journal of Pharmacology, Vol. 430, Iss. 1, 2001-10 ,pp. : 49-58

Elsevier

Access to resources Recommend Favorite

The cannabinoid CB 1 receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus

By Tzavara E.T.   Perry K.W.   Rodriguez D.E.   Bymaster F.P.   Nomikos G.G.  

European Journal of Pharmacology, Vol. 426, Iss. 3, 2001-08 ,pp. : 3-4

Elsevier

Access to resources Recommend Favorite